Tilray Brands, Inc. (TLRY)
Should You Buy, Sell or Hold TLRY Stock Post Q2 Earnings?
Tilray Brands posts record Q2 revenue of $217.5M, beats sales estimates, reaffirms EBITDA outlook as international cannabis and distribution offset beverage weakness.
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
Tilray Brands Readies for Q2 Earnings: Here's What You Should Know
TLRY's faces margin pressure in cannabis and beverages, but management sees a beverage turnaround and wellness strength cushioning quarterly results.
Tilray Brands, Inc. (TLRY) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Tilray Brands, Inc. (TLRY) closed at $10.42, indicating a -6.63% shift from the previous trading day.
Why Tilray Brands, Inc. (TLRY) Dipped More Than Broader Market Today
In the latest trading session, Tilray Brands, Inc. (TLRY) closed at $10.93, marking a -10.04% move from the previous day.
Tilray Brands, Inc. (TLRY) Crossed Above the 20-Day Moving Average: What That Means for Investors
Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 20-day moving average, suggesting a short-term bullish trend.
Tilray Brands, Inc. (TLRY) Just Overtook the 200-Day Moving Average
Tilray Brands, Inc. (TLRY) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, TLRY crossed above the 200-day moving average, suggesting a long-term bullish trend.
Tilray Brands Soars on Reports of Likely US Marijuana Reclassification
TLRY surges 44.1% on reports that Trump may reclassify marijuana, sparking hopes for eased federal rules and renewed investor enthusiasm.
Why Tilray Stock Soared This Week
President Trump is reportedly considering an executive order on marijuana reclassification. The order could come as early as Monday.
Tilray's stock takes off on hope that cannabis will soon be treated more like steroids than heroin
Tilray's stock, and shares of other cannabis companies, soared after reports provided investors hope that President Trump would move to have marijuana reclassified as a much less dangerous drug than it is now.
Tilray Stock Soars on Reclassification Buzz
Tilray Brands Inc (NASDAQ:TLRY) stock is soaring today, after the Washington Post reported that U.S. President Donald Trump plans to reclassify marijuana and dramatically loosen restrictions.
